A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection
Status:
Completed
Trial end date:
2020-03-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of open-label exposure of
gNO in patients with NTM lung disease. Subjects will receive the study drug by inhaling
through a nasal mask. Subjects will be treated for 3 weeks (5 days per week) and followed
monthly for 3 months.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics Oregon Health and Science University